Label-free quantitative proteomic analysis reveals dysfunction of complement pathway in peripheral blood of schizophrenia patients: evidence for the immune hypothesis of schizophrenia.
Schizophrenia is a complex mental disease caused by a combination of serial alterations in genetic and environmental factors. Although the brain is usually considered as the most relevant organ in schizophrenia, accumulated evidence suggests that peripheral tissues also contribute to this disease. In particular, abnormalities of the immune system have been identified in the peripheral blood of schizophrenia patients. To screen the serum proteomic signature of schizophrenia patients, we conducted shotgun proteomic analysis on serum samples of schizophrenia patients and healthy controls. High-abundance proteins were eliminated by immunoaffinity before LC-MS/MS analysis. The multivariate statistical test partial least squares-discriminant analysis (PLS-DA) was applied to build models for screening out variable importance in the projection (VIP) and 27 proteins were identified as being responsible for discriminating between the proteomic profiles of schizophrenia patients and healthy controls. Pathway analysis based on these 27 proteins revealed that complement and coagulation cascades was the most significant pathway. ELISA-based activity analyses indicated that the alternative complement pathway was suppressed in schizophrenia patients. Ingenuity pathways analysis was used to conduct the interaction network of 27 proteins. The network exhibited common features such as, nervous system development and function, humoral immune response and inflammatory response, and highlighted some proteins with important roles in the immune system, such as hub nodes. Our findings indicate dysregulation of the alternative complement pathway in schizophrenia patients. The protein interaction network enhances the interpretation of proteomic data and provides evidence that the immune system may contribute to schizophrenia.
Bio-X Center, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, 1954 Huashan Road, Shanghai 200030, China.
Yang
Y
Li
Kejun
K
Zhou
Zhao
Z
Zhang
Liya
L
Sun
Jinglei
J
Yang
Ming
M
Zhang
Baohu
B
Ji
Kefu
K
Tang
Zhiyun
Z
Wei
Guang
G
He
Linghan
L
Gao
Lun
L
Yang
Peng
P
Wang
Ping
P
Yang
Guoying
G
Feng
Lin
L
He
Chunling
C
Wan
D000328:Adult; D014150:Antipsychotic Agents / Q000494:pharmacology; D001921:Brain / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D016022:Case-Control Studies; D002853:Chromatography, Liquid; D003170:Complement Pathway, Alternative / Q000187:drug effects; D003165:Complement System Proteins / Q000276:immunology* / Q000378:metabolism; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D007113:Immunity, Innate; D016018:Least-Squares Analysis; D008297:Male; D008875:Middle Aged; D025941:Protein Interaction Mapping; D040901:Proteomics / Q000379:methods* / Q000706:statistics & numerical data; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy / Q000276:immunology*; D053719:Tandem Mass Spectrometry
D014150:Antipsychotic Agents; D003165:Complement System Proteins